Sinopharm Group Dividends and Buybacks
Dividend criteria checks 5/6
Sinopharm Group is a dividend paying company with a current yield of 4.61% that is well covered by earnings.
Key information
4.6%
Dividend yield
0.02%
Buyback Yield
| Total Shareholder Yield | 4.6% |
| Future Dividend Yield | 4.9% |
| Dividend Growth | 14.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €0.956 |
| Payout ratio | 31% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: X2S's dividends per share have been stable in the past 10 years.
Growing Dividend: X2S's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Sinopharm Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (X2S) | 4.6% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.9% |
| Industry Average (Healthcare) | 2.8% |
| Analyst forecast (X2S) (up to 3 years) | 4.9% |
Notable Dividend: X2S's dividend (4.61%) is higher than the bottom 25% of dividend payers in the German market (1.73%).
High Dividend: X2S's dividend (4.61%) is low compared to the top 25% of dividend payers in the German market (4.81%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (31.3%), X2S's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (16%), X2S's dividend payments are well covered by cash flows.